41.46
-0.86
(-2.03%)
At close: January 10 at 9:35:42 PM GMT+1
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 6XC.SG | -- | -- | -- | -- |
| S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | Baird: Outperform to Outperform | 12/2/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/2/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/11/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 10/28/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 8/12/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 7/31/2024 |
Related Tickers
LIXT Lixte Biotechnology Holdings, Inc.
2.5900
+12.61%
PBLA Panbela Therapeutics, Inc.
0.3700
+2.49%
QLGN Qualigen Therapeutics, Inc.
4.2800
+2.64%
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%
RGBP Regen BioPharma, Inc.
0.1000
+25.00%
KTTA Pasithea Therapeutics Corp.
2.5600
-10.49%
ENTO Entero Therapeutics, Inc.
0.5899
-4.85%
VCNX Vaccinex, Inc.
1.1500
+21.05%
OVID Ovid Therapeutics Inc.
0.8207
-9.80%
AZTR Azitra, Inc.
0.3600
-8.30%